Patent details

Basic Information

Publication number:

EP3699162

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP192142982

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HETERODIMERS OF GLUTAMIC ACID

French Title of Invention:

HÉTÉRODIMÈRES D'ACIDE GLUTAMIQUE

German Title of Invention:

HETERODIMERE VON GLUTAMINSÄURE

SPC Number:

Dates

Filing date:

07/11/2007

Grant date:

29/06/2022

EP Publication Date:

26/08/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/06/2022

EP B1 Publication Date:

29/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/11/2022

Expiration date:

07/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/06/2022

 

 

Name:

Molecular Insight Pharmaceuticals, Inc.

Address:

One World Trade Center 47th Floor, Suite J, New York, NY 10007, United States (US)

Inventor

1

Name:

BABICH, John W.

Address:

United States (US)

2

Name:

MARESCA, Kevin P.

Address:

United States (US)

3

Name:

ZIMMERMAN, Craig N.

Address:

United States (US)

Priority

1

Priority Number:

857490 P

Priority Date:

08/11/2006

Priority Country:

United States (US)

2

Priority Number:

878678 P

Priority Date:

05/01/2007

Priority Country:

United States (US)

Classification

IPC classification:

C07B 59/00; A61K 51/00;

Publication

European Patent Bulletin

Issue number:

202226

Publication date:

29/06/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages